Telesis Bio, Inc. (TBIO)
OTCMKTS
· Delayed Price · Currency is USD
0.367
+0.017 (4.86%)
Jan 31, 2025, 4:00 PM EST
Telesis Bio Employees
As of December 31, 2023, Telesis Bio had 147 total employees, including 137 full-time and 10 part-time employees. The number of employees decreased by 96 or -39.51% compared to the previous year.
Employees
147
Change (1Y)
-96
Growth (1Y)
-39.51%
Revenue / Employee
$436,769
Profits / Employee
-$1,228,872
Market Cap
652.27K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 147 | -96 | -39.51% |
| Dec 31, 2022 | 243 | 7 | 2.97% |
| Dec 31, 2021 | 236 | 145 | 159.34% |
| Dec 31, 2020 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 109 |
| CytoDyn | 9 |
| SANUWAVE Health | 31 |
Telesis Bio News
- 4 months ago - Dow Surges Over 250 Points; Accenture Earnings Top Views - Benzinga
- 4 months ago - What's Going On With Telesis Bio Shares Thursday? - Benzinga
- 4 months ago - Crude Oil Down Over 2%; US Initial Jobless Claims Fall - Benzinga
- 4 months ago - Telesis Bio partners with Danaher company Beckman Coulter - Seeking Alpha
- 4 months ago - Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket - Benzinga
- 4 months ago - Telesis Bio Stock Is Soaring Wednesday: What's Going On? - Benzinga
- 4 months ago - Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis - GlobeNewsWire
- 4 months ago - Nasdaq Surges 400 Points; US Jobless Claims Fall To 219,000 - Benzinga